• 1
    Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M. et al., Innate or adaptive immunity? The example of natural killer cells. Science. 2011. 331: 4449.
  • 2
    Parham, P., MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005. 5: 201214.
  • 3
    Stern, M., Ruggeri, L., Capanni, M., Mancusi, A. and Velardi, A., Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. Blood. 2008. 112: 708710.
  • 4
    Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V. et al., Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006. 25: 331342.
  • 5
    Morvan, M., David, G., Sebille, V., Perrin, A., Gagne, K., Willem, C., Kerdudou, N. et al., Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur. J. Immunol. 2008. 38: 34743486.
  • 6
    Trundley, A., Frebel, H., Jones, D., Chang, C. and Trowsdale, J., Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 2007. 37: 780787.
  • 7
    O'Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P. and Gardiner, C. M., Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 2007. 178: 235241.
  • 8
    Gillespie, G. M., Bashirova, A., Dong, T., McVicar, D. W., Rowland-Jones, S. L. and Carrington, M., Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res. Hum. Retroviruses 2007. 23: 451455.
  • 9
    Morvan, M., Willem, C., Gagne, K., Kerdudou, N., David, G., Sebille, V., Follea, G. et al., Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1 +NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J. Immunol. 2009. 182: 67276735.
  • 10
    Single, R. M., Martin, M. P., Meyer, D., Gao, X. and Carrington, M., Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 2008. 60: 711725.
  • 11
    Middleton D, Williams, F. and Halfpenny, I. A., KIR genes. Transpl. Immunol. 2005. 14 135142.
  • 12
    Denis, L., Sivula, J., Gourraud, P. A., Kerdudou, N., Chout, R., Ricard, C., Moisan, J. P. et al., Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005. 66: 267276.
  • 13
    Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D. et al., Human diversity in killer cell inhibitory receptor genes. Immunity 1997. 7: 753763.
  • 14
    Uhrberg, M., The KIR gene family: life in the fast lane of evolution. Eur. J. Immunol. 2005. 35: 1015.
  • 15
    Robinson, J., Mistry, K., McWilliam, H., Lopez, R. and Marsh, S. G., IPD–the Immuno Polymorphism Database. Nucleic Acids Res. 2010. 38(Database issue): D863869.
  • 16
    Parham, P., Norman, P. J., Abi-Rached, L. and Guethlein, L. A., Variable NK cell receptors exemplified by human KIR3DL1/S1. J. Immunol. 2011. 187: 1119.
  • 17
    Norman, P. J., Abi-Rached, L., Gendzekhadze, K., Korbel, D., Gleimer, M., Rowley, D., Bruno, D. et al., Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 2007. 39: 10921099.
  • 18
    Gumperz, J. E., Valiante, N. M., Parham, P., Lanier, L. L. and Tyan, D., Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype. J. Exp. Med. 1996. 183: 18171827.
  • 19
    Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C. et al., Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 2001. 166: 29923001.
  • 20
    Gardiner, C. M., Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int. J. Immunogenet. 2008. 35: 18.
  • 21
    Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y. J., French, A. R., Vlahiotis, A. et al., HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 2008. 105: 30533058.
  • 22
    Stewart, C. A., Van Bergen, J. and Trowsdale, J., Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 2003. 170: 60736081.
  • 23
    Chan, H. W., Kurago, Z. B., Stewart, C. A., Wilson, M. J., Martin, M. P., Mace, B. E., Carrington, M. et al., DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 2003. 197: 245255.
  • 24
    Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P. et al., Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 2007. 178: 3337.
  • 25
    Boulet, S., Song, R., Kamya, P., Bruneau, J., Shoukry, N. H., Tsoukas, C. M. and Bernard, N. F., HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J. Immunol. 2010. 184: 20572064.
  • 26
    Stewart-Jones, G. B., di Gleria, K., Kollnberger, S., McMichael, A. J., Jones, E. Y. and Bowness, P., Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 2005. 35: 341351.
  • 27
    Carr, W. H., Pando, M. J. and Parham, P., KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 2005. 175: 52225229.
  • 28
    Foley, B. A., De Santis, D., Van Beelen, E., Lathbury, L. J., Christiansen, F. T. and Witt, C. S., The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood. 2008. 112: 435443.
  • 29
    Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S. et al., Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 2007. 39: 733740.
  • 30
    Gagne, K., Busson, M., Bignon, J. D., Balère-Appert, M. L., Loiseau, P., Dormoy, A., Dubois, V. et al., Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 2009. 15: 13661375.
  • 31
    Yawata, M., Yawata, N., Draghi, M., Little, A. M., Partheniou, F. and Parham, P., Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006. 203: 633645.
  • 32
    Thomas, R., Yamada, E., Alter, G., Martin, M. P., Bashirova, A. A., Norman, P. J., Altfeld, M. et al., Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J. Immunol. 2008. 180: 67436750.
  • 33
    Halfpenny, I. A., Middleton, D., Barnett, Y. A. and Williams, F., Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum. Immunol. 2004. 65: 602612.
  • 34
    Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L. and Parham, P., The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 2003. 171: 66406649.
  • 35
    Taner, S. B., Pando, M. J., Roberts, A., Schellekens, J., Marsh, S. G., Malmberg, K. J., Parham, P. et al., Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J. Immunol. 2011. 186: 6272.
  • 36
    O'Connor, G. M., Yamada, E., Rampersaud, A., Thomas, R., Carrington, M. and McVicar, D. W., Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1. J. Immunol. 2011. 187: 21622171.
  • 37
    Single, R. M., Martin, M. P., Gao, X., Meyer, D., Yeager, M., Kidd, J. R., Kidd, K. K. et al., Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 2007. 39: 11141119.
  • 38
    Diaz-Pena, R., Vidal-Castineira, J. R., Alonso-Arias, R., Suarez-Alvarez, B., Vicario, J. L., Solana, R., Collantes, E. C. et al., Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum. 2010. 62: 10001006.
  • 39
    Vely, F., Peyrat, M., Couedel, C., Morcet, J., Halary, F., Davodeau, F., Romagne, F. et al., Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 2001. 166: 24872494.
  • 40
    Li, H., Pascal, V., Martin, M. P., Carrington, M. and Anderson, S. K., Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 2008. 4: e1000254.
  • 41
    Schonberg, K., Sribar, M., Enczmann, J., Fischer, J. C. and Uhrberg, M., Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 2011. 117: 98107.
  • 42
    Fischer, J. C., Ottinger, H., Ferencik, S., Sribar, M., Punzel, M., Beelen, D. W., Schwan, M. A. et al., Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J. Immunol. 2007. 178: 39183923.
  • 43
    Miller, J. S. and McCullar, V., Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001. 98: 705713.
  • 44
    Schönberg, K., Fischer, J. C., Kögler, G. and Uhrberg, M., Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood. 2011. 117: 51525156.
  • 45
    Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C+ NK cells: expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447457.
  • 46
    Charoudeh, H. N., Terszowski, G., Czaja, K., Gonzalez, A., Schmitter, K. and Stern, M., Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur. J. Immunol. 2012. 43: 18.
  • 47
    Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood. 2012. 119: 26652674.
  • 48
    Björkström, N. K., Svensson, A., Malmberg, K. J., Eriksson, K. and Ljunggren, H. G., Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One 2011. 6: 15.
  • 49
    Ballan, W. M., Vu, B. A., Long, B. R., Loo, C. P., Michaëlsson, J., Barbour, J. D., Lanier, L. L. et al., Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J. Immunol. 2007. 179: 33623370.
  • 50
    Ravet, S., Scott-Algara, D., Bonnet, E., Tran, H. K., Tran, T., Nguyen, N., Truong, L. X. et al., Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007. 109: 42964305.
  • 51
    Miller SA, D. D. and Polesky, H. F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988. 16: 1215.
  • 52
    Sun, J., Gaidulis, L., Miller, M., Goto, R., Rodriguez, R., Forman, S. and Senitzer, D., Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004. 64: 462468.
  • 53
    Gagne, K., Brizard, G., Gueglio, B., Milpied, N., Herry, P., Bonneville, F., Cheneau, M. L. et al., Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum. Immunol. 2002. 63: 271280.
  • 54
    Rasmussen, A. M., Smeland, E. B., Erikstein, B. K., Caignault, L. and Funderud, S., A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods 1992. 146: 195202.
  • 55
    David, G., Morvan, M., Gagne, K., Kerdudou, N., Willem, C., Devys, A., Bonneville, M. et al., Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology 2009. 128: 172184.